// App-Quantinova.ai

2103-281 : THE SAFETY AND EFFICACY OF ULTRA-LONG 2ND GENERATION DRUG ELUTING STENT IMPLANTATION

Researchers

Presenter

  • Yohsuke Honda

Principal Investigators

  • N/A

Medical Centers

  • Saiseikai Yokohama-city Eastern Hospital, Yokohama, kanagawa, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Chronic total occlusion

  • Restenosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved